Image Description

What is International Cancer Alliance for Research and Education (ICARE)?

Welcome to ICARE…

The International Cancer Alliance for Research and Education (ICARE) is a multinational,  501(c)(3) non-profit network of global cancer scientists, doctors, and patients. They work in collaboration to identify, evaluate, personalize, and accelerate access to emerging therapeutic options or technologies. ICARE does this by creating personalized exploratory or Investigative Teams (I-Teams) which begin locally with one patient, one doctor and one cancer researcher.  As global participants join the ICARE network, these Investigative Teams (I-Teams) allow individual patients and their local doctors to participate in real-time, personalized academic research projects and these projects are driven solely by patient needs and are not limited by institutional and national boundaries.

“Nobody cares for me like ICARE”

April Pierson-Keating 
Source Details

Why Choose Us?

Managing a life-threatening or life-disrupting illness is often accompanied by a feeling of being overwhelmed. Compounding the physiological impact of the disease, you brave through myriad tests, doctors’ visits, and critical decisions regarding procedures and medications-often while second-guessing whether you’re making the right choices. To help guide you through the process, we are providing you with an unprecedented level of support through a global consortium of physicians and research scientists conferring with you and your personal doctor every step of the way.

1) ICARE was founded and is managed by academic medical scientists and doctors

2) An increasing number of our cancer registrants are scientists/doctors or members of their family

3) With ICARE you can join, support, and learn from creative scientists who are pursuing technologies that may directly benefit you and your doctor

4) Due to ICARE’s live-tissue biobanking contacts, your tissues can be biologically tested for their sensitivity to various global therapeutic options, biomarker and clinical studies

5) After 30 years of distributing therapeutic options and diagnostic advances to the general public, ICARE has switched to creating and funding real-time investigative teams to urgently collaborate, identify, evaluate and accelerate access global options for local patients and their doctors.

ICARE’s Approach to Cancer Patient Care

In recent years, ICARE’s programs began to shift in focus from just providing therapy information to patients to identifying, initiating and funding cutting-edge research projects to “target for destruction”, the tumors of individual patients. In 2010 some of the ICARE global scientists accepted the challenge of partnering with local individual cancer patients and their doctors to form a type of “Manhattan Project” that would try and find viable solutions in “real-time” for immediate clinical issues facing the doctor and patient. Virtual Global Investigative Teams (I-Teams) were assembled and a new approach to patient care called the 10-Step I-Team Process.

Leaderships, Partners, And Sponsors:

The list of Volunteers below includes individuals who have served in the past or are currently serving on
ICARE boards, committees or as advisors. These lists are intended only to illustrate the high quality of
individuals who have been attracted to participate in ICARE programs.

Name, Title Location Name, Title Location
Henry Brem, M.D. Johns Hopkins University Michael Link, M.D. Stanford University
Daniel Brookoff, M.D., Ph.D Reed Baskin Cancer Center Marc Lippman, M. D. Miami University
Stanley Cohen, Ph.D.* Vanderbilt University Susan M. Love, M.D. UCLA
Anthony Coletta, Ph.D. Cambridge University Hans Messner, Ph.D. Toronto, Canada
Nancy E. Davidson, M.D. Johns Hopkins University Yasuda Muira, M.D. Jichi Medical School, Japan
Allen Eaves, M.D. Vancouver, Canada Wolfram Ostertag, Ph. D. Hamburg, Germany
Marc Garnick, M.D. Harvard University Howard Pearson, M.D. Yale University
Donna Williams, Ph. D. Memorial Sloan-Kettering William Peters, M.D. Duke/Wayne St. University
Alfred L. Goldson, M.D. Howard University Bernard Poiesz, M. D. SUNY/Syracuse
James S. Gordon, M.D. Ctr. For Mind-Body Medicine Martin Dreyling, M.D. Univ. Munich, Germany
Melvyn Greaves, Ph. D. London, England Jack A. Schalken, Ph.D. Univ. Nijmegen
Jimmie C. Holland, M.D. Memorial Sloan-Kettering Anil K. Rustgi, M.D. Netherlands
Deane Jacques, M.D. Neuroscience Institute Gordon Sato, Ph. D. Harvard University
Junyao Li , M. D. Beijing Med. Sch., China Andrew V. Schally, Ph. D.* Tulane University
Benita Katzenellenbogen, Ph.D University of Illinois Jerry L. Spivak, M. D. Johns Hopkins University
Byoung-Kook Kim, M.D. Seoul, South Korea Arthur J. Sytkowski, M.D. Harvard University
Raymond Kuhn, Ph.D Wake Forest University

*Nobel Laureate


Board of Trustees

Name, Title Location
W. David Hankins, Ph.D ICARE Chairmen, Bethesda, MD
Raymond Kuhn, Ph.D Wake Forest University, Winston-Salem, NC
George Hemstreet, M.D., Ph.D Univ. Nebraska Med. Sch, Omaha, Nebraska
Steve Radabough Germantown, MD
Junvao Li, M.D Beijing Medical School, China
Robert Barnett, M.D. Surgical Oncology, Rockville, MD
Marjorie Margolies-Mezvinsky Former Member of Congress, Narberth, Pennsylvania
Charles Rodgers, Ph.D National Institute of Health, Bethesda, MD
Nancy Prime Iowa


Trustees Advisory Board

Name, Title Name, Title Name, Title Name, Title
Joseph Charyk Colleen Nunn Eiyind Bjerke Shelley Mulitz
C. Boyden Gray Denise O’ Neil Buffy Cafritz Pamela Ohrstrom
Susan J. Blumenthal, M.D. David Smith Jean Wallace Douglas Chuck Stone
Margo Hauer Deborah Szekely Ann Jordan Faith Waters
Alyne Massey Robert K. Zelle Cynthia Helms Gerry Ohrstrom


Friends of ICARE

Susan Saint James, Eric Johanson, Craig Nalen, Christopher Rodgers, and Sen. Fred D. Thompson


Frequently Asked Questions:

What happens after I register or donate?

You will receive a receipt in your inbox for confirmation. If it did not show up in your inbox, check your spam or junk folder.

What does the mailing list refer to?

By confirming your choice of joining the mailing list, you will receive future emails from Mailchimp.

What is Flipcause?

Flipcause is a fundraising platform for non-profits. When you donate, or participate in a campaign related to ICARE.org, Flipcause provides the platform to carry out these activities.

What is the donating processing fee for?

When donating, you will see the statement: “I’d like to cover the processing fee so 100% of my contribution goes to iCARE.” Flipcause provides their services at a charge to ICARE.org. When donating, if you would like to cover the fees, you can leave this statement checked. If not, you may uncheck this statement.